Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study).
BMC Med
; 20(1): 478, 2022 Dec 08.
Article
in English
| MEDLINE | ID: covidwho-2162366
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Type of study:
Experimental Studies
/
Randomized controlled trials
Language:
English
Journal:
BMC Med
Journal subject:
Medicine
Year:
2022
Document Type:
Article
Affiliation country:
S12916-022-02695-5
Similar
MEDLINE
...
LILACS
LIS